This tool aims to predict prognosis in patients with colorectal cancer who initiate FOLFIRI-aflibercept after progression to oxaliplatin-based regimens. This tool is intended only for individuals with these characteristics; hence, the eligibility criteria will be checked before you can access the calculator.
The data come from a multicenter registry that represents the clinical practice patterns of the participating centers. Although this model offers an overview, bear in mind that a minority of your patients may have unusual prognostic factors, which could significantly affect the clinical evolution.
Predictions are merely approximate, so decisions should be made at the discretion of the attending physician.